Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bourge

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Pulmonary Circulation|September 30, 2016
An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertensionR T Zamanian, D J Levine, R C Bourge, et al.
The American Journal of Cardiology|July 25, 1998
Efficacy of coronary stenting in the management of cardiac allograft vasculopathyP M Wong, C Piamsomboon, A Mathur, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 8, 1998
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research DatabaseM R Costanzo, D C Naftel, M R Pritzker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trialJ A Kobashigawa, J M Tobis, R M Mentzer, et al.
The New England Journal of Medicine|July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study GroupW S Colucci, U Elkayam, D P Horton, et al.
The American Journal of Cardiology|September 1, 1996
Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid RegistryC M Ballantyne, R C Bourge, L J Domalik, et al.
Circulation|June 29, 1999
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertensionD Langleben, R J Barst, D Badesch, et al.
The New England Journal of Medicine|February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionR J Barst, L J Rubin, W A Long, et al.
Transplantation|October 3, 1999
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Pulmonary Circulation|September 30, 2016
An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertensionR T Zamanian, D J Levine, R C Bourge, et al.
The American Journal of Cardiology|July 25, 1998
Efficacy of coronary stenting in the management of cardiac allograft vasculopathyP M Wong, C Piamsomboon, A Mathur, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 8, 1998
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research DatabaseM R Costanzo, D C Naftel, M R Pritzker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trialJ A Kobashigawa, J M Tobis, R M Mentzer, et al.
The New England Journal of Medicine|July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study GroupW S Colucci, U Elkayam, D P Horton, et al.
The American Journal of Cardiology|September 1, 1996
Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid RegistryC M Ballantyne, R C Bourge, L J Domalik, et al.
Circulation|June 29, 1999
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertensionD Langleben, R J Barst, D Badesch, et al.
The New England Journal of Medicine|February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionR J Barst, L J Rubin, W A Long, et al.
Transplantation|October 3, 1999
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Pageof 9